Dexcom | DXCM - 销售毛利



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.65B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


销售毛利 更改 日
Abbott USD 6.65B 787M 2026-06
Align Technology USD 757.43M 20.84M 2026-06
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 1.14B 251M 2026-06
Becton, Dickinson and Co. USD 2.32B 161M 2026-06
Boston Scientific USD 3.82B 210M 2026-06
Cooper Companies USD 711.9M 23.5M 2026-06
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Globus Medical USD 548.17M 51.91M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 562.6M 21.8M 2026-06
Integra LifeSciences USD 215.97M 2.77M 2026-06
J&J USD 18.55B 1.31B 2026-06
Medtronic USD 6.36B 355M 2026-06
Merit Medical Systems USD 215.17M 30.37M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Solventum Corp USD 1.29B 189M 2026-06
Stryker USD 4.5B 688M 2026-06
Tandem Diabetes Care USD 144.78M 7.99M 2026-06
Teleflex USD 331.71M 24.28M 2026-06
West Pharmaceutical Services USD 296.4M 7.5M 2026-03
Zimmer Biomet Holdings USD 1.36B 149.4M 2026-06